Author

Roberto Chiarle

h-index 7 View on Semantic Scholar

We have 2 of 48 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Cancers modulate processing and presentation of p53 neoantigens to evade T cell detection.

Findings define mechanisms by which tumors restrict targetable truncal truncal neoantigen display and suggest immunopeptidome shift strategies to circumvent immune escape.

Koji Haratani, Bruce R. Reinhold, J. Duke-Cohan et al. · Immunity · 0 citations

Review Open access Aug 2026

Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives

AlK-specific immunotherapies, including ALK vaccines, ALK CAR-T and other cellular therapies, as well as ALK-targeting antibodies with a particular focus on pediatric ALK-positive tumors are discussed.

Monica Maccagno, Roberta Tagliero, Roberto Chiarle et al. · Frontiers in Immunology · 0 citations